课题基金 / 基金详情

New Risk Assessment Paradigm to Predict Screening Detection, Failures and False Alarms

New Risk Assessment Paradigm to Predict Screening Detection, Failures and False Alarms
新的风险评估范式可预测筛查检测、故障和误报
批准号:
9982825
负责人:
KARLA M KERLIKOWSKE
金额:
$27.72万
依托单位国家:
美国
项目类别:
财政年份:
2020
资助国家:
美国
项目状态:
已结题
起止时间:
2020-06-01 至 2022-05-31

项目摘要

项目成果

KARLA M KERLIKOWSKE的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
PROJECT SUMMARY – Project 1 The 2016 US Preventive Services Task Force and 2015 American Cancer Society guidelines call for reduced screening intensity and for providers to discuss with women their preferences for screening. This push for individualized decision-making has triggered substantial movement toward risk-based screening utilization that does not rely solely on a woman's age to determine when to start and stop screening or screening frequency. Yet, the explicit incorporation of risk assessment into screening guidelines for the general population is in its early stages. Risk prediction is a key aspect of risk-based screening; available models predict breast cancer risk overall, but do not take into account the heterogeneity of breast cancer biology or the ability of screening modalities to detect breast cancer. Project 1 aims to advance a new risk-based screening paradigm that identifies women's absolute cumulative risk of screening detection, failures, and false alarms while explicitly considering screening interval and modality used. Aim 1) Using the existing and expanded Breast Cancer Surveillance Consortium (BCSC) infrastructure, project investigators will develop new risk prediction models to identify women at high risk of: 1) early-stage screen-detected cancer (stage I/IIa invasive cancer), 2) screening failure (interval invasive cancer or screen-detected stage IIb or higher), and 3) false alarms (false-positive tests and benign biopsies). Using BCSC data on over 1,000,000 women aged 40-79 years undergoing digital mammography or tomosynthesis, and over 13,000 invasive breast cancers identified, the project team will identify clinical and imaging factors associated with breast cancer risk that impact screening outcomes, generating six-year risk estimates for each screening outcome for annual, biennial, and triennial screening regimens. Aim 2) The project team will identify actionable levels of clinically-meaningful risk of screening failure and false alarm, and associated long-term screening outcomes using women and clinician surveys and Delphi panels. This proposal will answer: 1) Which women are at high risk of screening failures and require an alternative strategy to biennial mammography, and which women are at low risk and can be screened less often? 2) What risk levels of poor screening outcomes impact women and clinician preferences for screening strategies? This project will provide evidence to guide women, health care providers, and policymakers on screening strategies based on short-term risk of screening failures and false alarms with the goal to improve early detection of aggressive tumors while minimizing harms.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Hawaii Pacific Islands Mammography Registry
  • 批准号:
    10819068
  • 项目类别:
  • 资助金额:
    $5.55万
  • 财政年份:
    2023
  • 负责人:
    KARLA M KERLIKOWSKE
  • 依托单位:
Hawaii Pacific Islands Mammography Registry
  • 批准号:
    10588112
  • 项目类别:
  • 资助金额:
    $68.89万
  • 财政年份:
    2023
  • 负责人:
    KARLA M KERLIKOWSKE
  • 依托单位:
Evaluation of novel tomosynthesis density measures in breast cancer risk prediction
  • 批准号:
    10680241
  • 项目类别:
  • 资助金额:
    $70.18万
  • 财政年份:
    2023
  • 负责人:
    KARLA M KERLIKOWSKE
  • 依托单位:
New Risk Assessment Paradigm to Predict Screening Detection, Failures and False Alarms
  • 批准号:
    9279002
  • 项目类别:
  • 资助金额:
    $29.69万
  • 财政年份:
    2017
  • 负责人:
    KARLA M KERLIKOWSKE
  • 依托单位:
国内基金
海外基金
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
  • 批准号:
    JCZRQN202500010
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2025
  • 负责人:
  • 依托单位:
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
  • 批准号:
    2025JJ70209
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2025
  • 负责人:
    雷芬芳
  • 依托单位:
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
  • 批准号:
    --
  • 项目类别:
    面上项目
  • 资助金额:
    --
  • 批准年份:
    2024
  • 负责人:
    万荣
  • 依托单位: